Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists

Prospective Post Marketing Surveillance To Evaluate The Safety And Efficacy Of Etanercept Under Usual Care Settings In Patients With Psoriatic Arthritis (Psa) Treated By Dermatologists

The purpose of this study is to evaluate the safety profile and the effectiveness of etanercept under usual care settings in patients with PsA treated by dermatologists.

Non-interventional study: subjects to be selected according to the usual clinical practice of their physician

Inclusion Criteria:

• Clinical diagnosis of Psoriatic Arthritis

Exclusion Criteria:

• Sepsis or risk for sepsis,
• Acute infection,
• Hypersensitive against Etanercept